Pelthos Therapeutics Inc. PTHS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.91M+16.2% | $9.39M+26.8% | $7.41M— | $0— | $0— | ||
| $1.67M+0.1% | $1.67M-27.8% | $2.32M— | $0— | $0— | ||
| $9.23M+19.6% | $7.72M+51.6% | $5.09M— | $0— | $0— | ||
| 84.7%+2.5pp | 82.2%+13.5pp | 68.7%— | —— | —— | ||
| $186K-50.3% | $374K+158% | $145K-71.8% | $514.81K+165% | $194K-31.9% | ||
| $21.1M+14.3% | $18.47M-5.9% | $19.63M+623% | $2.72M+65.6% | $1.64M+6.6% | ||
| $23.99M— | —— | —— | —— | $1.83M-3.1% | ||
| -$13.09M-9.0% | -$12M+21.9% | -$15.36M-376% | -$3.23M-76.1% | -$1.83M-0.5% | ||
| -120%+7.8pp | -127.8%+79.6pp | -207.4%— | —— | —— | ||
| $2.35M+79.1% | $1.31M-2.4% | $1.35M+517% | $218K+62.7% | $134K+24.1% | ||
| $2.85M+117% | -$16.58M-1,137% | -$1.34M-514% | -$218.52K-63.1% | -$134K-31.4% | ||
| -$10.24M+64.2% | -$28.59M-71.1% | -$16.7M-384% | -$3.45M-75.3% | -$1.97M-2.2% | ||
| $0+100% | -$6.92M-1,389% | -$465K— | $0— | $0— | ||
| -$10.24M+52.7% | -$21.66M-33.4% | -$16.24M-371% | -$3.45M-75.3% | -$1.97M-2.2% | ||
| -93.9%+137pp | -230.7%-11.5pp | -219.3%— | —— | —— | ||
| -$3.09— | —— | —— | —— | -$3.21+10.0% | ||
| -$11.59M-7.4% | -$10.79M+26.5% | -$14.68M-355% | -$3.23M-76.1% | -$1.83M-0.5% | ||
| -106.3%+8.6pp | -114.9%+83.4pp | -198.3%— | —— | —— | ||
| -$13.09M-9.0% | -$12M+21.9% | -$15.36M-376% | -$3.23M-76.1% | -$1.83M-0.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pelthos Therapeutics Inc.'s revenue?
- Pelthos Therapeutics Inc. (PTHS) generated $27.7M in revenue over the trailing twelve months.
- Is Pelthos Therapeutics Inc. profitable?
- Pelthos Therapeutics Inc. is not currently profitable: it reported a net loss of $51.6M over the trailing twelve months, a -186.2% net margin.
- What are Pelthos Therapeutics Inc.'s profit margins?
- Gross margin is 79.6% and operating margin is -157.7%, with a -186.2% net margin.
- What is Pelthos Therapeutics Inc.'s earnings per share?
- Pelthos Therapeutics Inc.'s diluted EPS over the trailing twelve months is $-13.44.
- Where does Pelthos Therapeutics Inc.'s income statement data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
